Breaking News

You are here » Indian-Commodity  :  Investment  :  Suven Life Science acquires Suven Pharmaceuticals

06-Feb2019

Suven Life Science acquires Suven Pharmaceuticals

Suven Life Science has acquired all the shares of Suven Pharmaceuticals (SPL), a public limited company, from its existing shareholders. Pursuant to which, Suven Pharmaceuticals has become a wholly owned subsidiary of the company. The board of directors at their meetings held on February 5, 2019 approved the same. The Board also approved draft Scheme of Arrangement to be filed at the National Company Law Tribunal bench at Hyderabad, for necessary approvals.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.


Related News

View all news

SpiceJet to start 12 new domestic flights from March 31

SpiceJet will start 12 new direct flights on its domestic network from March 31, 2019. The airline is the first Indian carrier to introduce daily direct flights on the Bhopal-Surat-Bhopal, Gorakhpur-Mumbai-Gorakhpur......

Aditya Birla Fashion to start apparel manufacturing plant in Odisha: Report

Aditya Birla Fashion and Retail is reportedly to start a new apparel manufacturing plant in Rayagda district of Odisha with an investment of Rs 114 crore. This unit will have a capacity to produce 3.6......

Power Grid gets investment approval for 'Northern Region System Strengthening - XL'

Power Grid Corporation of India has received an investment approval for 'Northern Region System Strengthening - XL' at an estimated cost of Rs 572.98 crore with commissioning schedule of 22 months from......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......